AURA
Aura Biosciences
$7.16
+$0.11 (+1.56%)Jul 27, 2026
Key metrics
The numbers that frame AURA today
- Market cap
- $740.25M
- P/E (TTM)
- -6.6
- EV / FCF
- -7.3
- ROIC
- -112.1%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $4.73
- 52wk High
- $9.54
Growth
Revenue and earnings trend for AURA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AURA
Is Aura Biosciences a good buy?
No. Aura Biosciences has strong momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Aura Biosciences is selling at a very high price.
What is the market capitalization of AURA?
Aura Biosciences's market capitalization is $740.25M.
What is the P/E ratio for AURA stock?
Aura Biosciences's current P/E ratio is -6.6.
What is the 52-week high for AURA stock?
The 52-week high for Aura Biosciences is $9.54. The current close of $7.16 is 24.9% below that high.
What is the 52-week low for AURA stock?
The 52-week low for Aura Biosciences is $4.73. The current close of $7.16 is 51.4% above that low.
Does AURA stock pay dividends?
Aura Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AURA?
Aura Biosciences's Debt / Equity ratio is 0.16.